While CAR T cell viability, expression of activation and exhaustion markers as well as their cytokine production was largely unaffected, CD4+ CAR T cell cytotoxicity was significantly reduced in the presence of neuroblastoma-derived extracellular vesicles independent of NTRK1/2 expression. The gene discussed is CD4; the disease is neuroblastoma.